161 related articles for article (PubMed ID: 9545146)
1. Population pharmacokinetics of carbamazepine in adults with epilepsy.
Graves NM; Brundage RC; Wen Y; Cascino G; So E; Ahman P; Rarick J; Krause S; Leppik IE
Pharmacotherapy; 1998; 18(2):273-81. PubMed ID: 9545146
[TBL] [Abstract][Full Text] [Related]
2. Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
Messina S; Battino D; Croci D; Mamoli D; Ratti S; Perucca E
Epilepsia; 2005 Mar; 46(3):372-7. PubMed ID: 15730534
[TBL] [Abstract][Full Text] [Related]
3. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data.
Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
Epilepsia; 2003 Jul; 44(7):923-9. PubMed ID: 12823575
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
Bae EK; Lee J; Shin JW; Moon J; Lee KJ; Shin YW; Kim TJ; Shin D; Jang IJ; Lee SK
Seizure; 2016 Apr; 37():8-12. PubMed ID: 26908152
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
Wagner ML; Graves NM; Marienau K; Holmes GB; Remmel RP; Leppik IE
Epilepsia; 1991; 32(3):398-406. PubMed ID: 1904346
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of carbamazepine in Singapore epileptic patients.
Chan E; Lee HS; Hue SS
Br J Clin Pharmacol; 2001 Jun; 51(6):567-76. PubMed ID: 11422016
[TBL] [Abstract][Full Text] [Related]
7. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
Carlsson KC; Hoem NO; Glauser T; Vinks AA
Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
Jankovic SM; Milovanovic JR
Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
[TBL] [Abstract][Full Text] [Related]
10. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
Graves NM; Holmes GB; Fuerst RH; Leppik IE
Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
[TBL] [Abstract][Full Text] [Related]
11. Steady state pharmacokinetics of carbamazepine-phenobarbital interaction in patients with epilepsy.
Sennoune S; Iliadis A; Bonneton J; Barra Y; Genton P; Mesdjian E
Biopharm Drug Dispos; 1996 Mar; 17(2):155-64. PubMed ID: 8907722
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data.
Jiao Z; Shi XJ; Zhao ZG; Zhong MK
J Clin Pharm Ther; 2004 Jun; 29(3):247-56. PubMed ID: 15153086
[TBL] [Abstract][Full Text] [Related]
13. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of carbamazepine in elderly patients.
Punyawudho B; Ramsay ER; Brundage RC; Macias FM; Collins JF; Birnbaum AK
Ther Drug Monit; 2012 Apr; 34(2):176-81. PubMed ID: 22406657
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of felbamate in children.
Kelley MT; Walson PD; Cox S; Dusci LJ
Ther Drug Monit; 1997 Feb; 19(1):29-36. PubMed ID: 9029743
[TBL] [Abstract][Full Text] [Related]
16. Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication.
Kong ST; Lim SH; Chan E; Ho PC
J Clin Pharmacol; 2014 Feb; 54(2):225-33. PubMed ID: 23996245
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
Jankovic SM; Jovanovic D; Milovanovic JR
Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of free carbamazepine in adult Omani epileptic patients.
Deleu D; Aarons L; Ahmed IA
Eur J Clin Pharmacol; 2001 Jun; 57(3):243-8. PubMed ID: 11497340
[TBL] [Abstract][Full Text] [Related]
19. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
